Lv21
110 积分 2023-08-04 加入
Implications of EGFR expression on EGFR signaling dependency and adaptive immunity against EGFR-mutated lung adenocarcinoma
6天前
已完结
HER4 and EGFR Activate Cell Signaling in NRG1 Fusion-Driven Cancers: Implications for HER2-HER3-specific Versus Pan-HER Targeting Strategies
10天前
已完结
Emerging importance of HER3 in tumorigenesis and cancer therapy
10天前
已完结
Coexpression of EGFr, HER2, HER3 and HER4 in primary human breast carcinoma
10天前
已完结
Recurrent early stage endometrial cancer: Patterns of recurrence and results of salvage therapy
17天前
已完结
Epidermal growth factor receptor (EGFR) as a target in cancer therapy: understanding the role of receptor expression and other molecular determinants that could influence the response to anti-EGFR drugs
23天前
已完结
Pan-cancer Comprehensive Analysis Identified EGFR as a Potential Biomarker for Multiple Tumor Types
23天前
已完结
ErbB receptors, their ligands, and the consequences of their activation and inhibition in the myocardium
23天前
已完结
251 Efficacy and safety of iparomlimab and tuvonralimab in previously treated patients with recurrent or metastatic cervical cancer: a multicenter, open-label, single-arm, phase 2 clinical trial (DUBHE-C-206)
1个月前
已完结
Efficacy and Safety of the Anti–PD-L1 mAb Socazolimab for Recurrent or Metastatic Cervical Cancer: a Phase I Dose-Escalation and Expansion Study
1个月前
已完结
皖公网安备34019202002308
